- AU$58.82m
- AU$64.29m
- AU$16.70m
Annual balance sheet for Cryosite, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
R2022 June 30th | 2023 June 30th | 2024 June 30th | 2025 June 30th | 2026 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 5.34 | 5.73 | 4.7 | 5.06 | 2.24 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.21 | 1.73 | 1.41 | 2.29 | 2.57 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 8.3 | 9.18 | 7.74 | 8.87 | 6.19 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 2.4 | 4.04 | 1.45 | 1.42 | 11.9 |
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 21.5 | 22.6 | 19.7 | 19.5 | 26 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 3.73 | 3.78 | 3.99 | 4.53 | 4.67 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 19.6 | 19.9 | 18.3 | 17.1 | 21.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 1.86 | 2.78 | 1.45 | 2.39 | 4.85 |
| Total Liabilities & Shareholders' Equity | 21.5 | 22.6 | 19.7 | 19.5 | 26 |
| Total Common Shares Outstanding |